关于新型冠状病毒（COVID-19）对瑞萨电子业务影响的通知

Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today announced the effects on Renesas Group’s production sites from the coronavirus disease (COVID-19) pandemic as of March 26, 2020.

1.Renesas Group’s production sites in Malaysia

Due to the Movement Control Order announced by the Malaysian government, Renesas Group’s three production sites located in Malaysia temporarily halted productions from March 18, 2020. The status of each of the sites are listed below:

·Renesas Semiconductor (Malaysia) Sdn. Bhd.
Partially resumed operation from March 21, 2020, and following the Malaysian governments’ instructions, as of March 26, the site is running at a limited capacity.

·Renesas Semiconductor KL Sdn. Bhd.
Partially resumed operation from March 26, 2020, and following the Malaysian governments’ instructions, the site is running at a limited capacity.

·Integrated Device Technology Malaysia Sdn. Bhd. (Note) 
Partially resumed operation from March 19, 2020, and following the Malaysian governments’ instructions, as of March 26, 2020, the site is running at a limited capacity.

(Note) As of April 1, 2020, Integrated Device Technology Malaysia Sdn. Bhd. Will change its name to Renesas Electronics (Penang) Sdn. Bhd

2.Renesas Group’s production sites in China

Although the below Renesas Group’s two production sites in China temporarily halted operations, production partially resumed from February 10, 2020, and as of March 26, 2020, are under normal operation.

žRenesas Semiconductor (Beijing) Co., Ltd.

žRenesas Semiconductor (Suzhou) Co., Ltd.

Although impacts from the production halt from the above mentioned Renesas’ Malaysian production sites will be additionally incorporated into Renesas Group’s consolidated forecasts for the three months ending March 31, 2020 announced on February 12, 2020, there are no revisions at this current time.

In closing, we would like to express best wishes for a speedy recovery to those who have been impacted by the COVID-19.